(Q52165773)

26 April 2018

title

PACAP38 and PACAP27 administered intracerebroventricularly have an opposite effect on LH secretion. (English)

1 reference

26 April 2018

author

Katalin Köves

4

1 reference

26 April 2018

author name string

Kántora O

1

1 reference

26 April 2018

Molnár J

2

1 reference

26 April 2018

Arimura A

3

1 reference

26 April 2018

publication date

1 June 2000

1 reference

26 April 2018

published in

Peptides

1 reference

26 April 2018

volume

21

1 reference

26 April 2018

issue

6

1 reference

26 April 2018

page(s)

817-820

1 reference

26 April 2018

Pituitary adenylate cyclase-activating polypeptide acts within the medial basal hypothalamus to inhibit prolactin and luteinizing hormone secretion

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900214-X

7 January 2021

Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900214-X

7 January 2021

Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900214-X

7 January 2021

Pituitary adenylate cyclase-activating polypeptide (PACAP) potentiates the gonadotropin-releasing activity of luteinizing hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900214-X

7 January 2021

Pituitary adenylate cyclase-activating peptide-38 (PACAP)-38 is released into hypophysial portal blood in the normal male and female rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900214-X

7 January 2021

Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900214-X

7 January 2021

Comparative distribution of immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900214-X

7 January 2021

Immunohistochemical demonstration of a novel hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide, in the ovine hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900214-X

7 January 2021

Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on prolactin, luteinizing hormone and growth hormone secretion in the ewe

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900214-X

7 January 2021

Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900214-X

7 January 2021

Effects of pulsatile pituitary adenylate cyclase activating polypeptide (PACAP) on gonadotropin secretion and subunit mRNA levels in perifused rat pituitary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900214-X

7 January 2021

Cytochemical characterization of anterior pituitary target cells for the neuropeptide, pituitary adenylate cyclase activating polypeptide (PACAP), using biotinylated ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900214-X

7 January 2021

Effects of GnRH and PACAP on gonadotropin secretion and subunit messenger RNAs.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900214-X

7 January 2021

10.1016/S0196-9781(00)00214-X

Identifiers

DOI

1 reference

26 April 2018

1 reference

26 April 2018